Ebrotidine
Authors:
- 1 June 1996
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 51 (6) , 974-980
Abstract
▴ Ebrotidine is the first of a new generation of H2 receptor antagonists with gastroprotective activity ▴ It stimulates epithelial cell proliferative activity and produces beneficial physicochemical changes in the gastric mucus that contribute to its gastroprotective action against ethanol-, aspirin- or stress-induced gastric mucosal damage ▴ The antisecretory properties of ebrotidine are similar to those of ranitidine and ≈ 10-fold greater than those of Cimetidine ▴ This drug exhibits anti-Helicobacter pylori activity that is synergistic with a number of antibacterial agents; it inhibits the urease enzyme and the proteolytic and mucolytic activities of H. pylori, and counteracts the inhibitory effects of H. pylori lipopolysaccharide ▴ Ebrotidine is as effective as ranitidine for the treatment of patients with gastric or duodenal ulcers or erosive reflux oesophagitis ▴ Ebrotidine therapy results in significantly better ulcer healing rates than ranitidine treatment in patients who smoke.Keywords
This publication has 21 references indexed in Scilit:
- Enhancement in the protective qualities of gastric mucus by ebrotidine during duodenal ulcer healingGeneral Pharmacology: The Vascular System, 1995
- Investigation of the metabolism of ebrotidine in human urine by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.Drug Metabolism and Disposition, 1995
- Effect of ebrotidine on the density of antral G‐cells in the gastric mucosa in the ratCell Proliferation, 1995
- Efficacy and safety of ebrotidine compared with ranitidine in patients with duodenal ulcer.1995
- Gastric mucosal EGF and PDGF receptor expression with ulcer healing by ebrotidine.1994
- Regulation of gastric mucosal calcium channel activity by an antiulcer agent, ebrotidine.1994
- Effect of ebrotidine on gastric mucosal EGF and PDGF receptor expression.1993
- Gastric acid inhibitory profile of ebrotidine, a novel H2-receptor antagonist in humans.1992
- Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of ebrotidine.1992
- Gastroprotective and Antisecretory Effects of EbrotidineScandinavian Journal of Gastroenterology, 1992